Treatment‐Related Risk Factors for Diabetes Mellitus in Childhood Cancer Survivors—A Case‐Cohort Study Within Adult Life After Childhood Cancer in Scandinavia (ALiCCS)
Pediatric Blood & Cancer · 2025
DOI: 10.1002/pbc.31805 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Line Kenborg und 18 weiteren Autor:innen. Beteiligte Einrichtung: Childhood Cancer Research Group, Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Cancer Survivors, Neoplasms, Diabetes Mellitus, Whole-Body Irradiation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Danish Council for Strategic Research, the Danish Childhood Cancer Foundation, the Swedish Childhood Cancer Fund.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The aim was to identify treatment‐related risk factors for diabetes in 5‐year survivors of childhood cancer (CCS). This case‐cohort study within Adult Life after Childhood Cancer in Scandinavia (ALiCCS) included 140 CCS with diabetes and a subcohort of 390 randomly selected CCS. Incidence rate ratios (IRRs) and 95% confidence intervals (CIs) were calculated to assess the association between treatment exposures and diabetes. Radiotherapy was the most important risk factor, with increased IRR after total body irradiation (TBI) (9.8, 95% CI = 2.9–33.7), abdominal radiation (4.8, 95% CI = 2.2–10.4), and cranial radiation (4.3, 95% CI = 2.1–8.8). Continued follow‐up with regard to diabetes is indicated after TBI, abdominal radiation, and cranial radiation in CCS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Childhood Cancer Research Group, Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark.
- Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
- Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA.
- Statistics and Data Analysis, Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark.
- Department of Pediatrics, Children's Medical Center, The National University Hospital of Iceland, Reykjavik, Iceland.
- Childhood Cancer Center, Skåne University Hospital, Lund, Sweden.
ORCID-Profile: Anja Krøyer, Henrik Hasle, Anna S Holmqvist
Förderung
- Danish Council for Strategic Research
- the Danish Childhood Cancer Foundation
- the Swedish Childhood Cancer Fund
- Strategiske Forskningsråd
Zitieren
APA
Kenborg, L., Asdahl, P. H., Bhatia, S., Christensen, J., Gudmundsdottir, T., Hjorth, L., Howell, R., Krøyer, A., Jørgensen, M., Laursen, M. R. T., Lassen-Ramshad, Y., de Fine Licht, S., Nielsen, T. T., Rechnitzer, C., Smith, S. A., Wiebe, T., Hasle, H., Holmqvist, A. S., & ALiCCS study group (2025). Treatment‐Related Risk Factors for Diabetes Mellitus in Childhood Cancer Survivors—A Case‐Cohort Study Within Adult Life After Childhood Cancer in Scandinavia (ALiCCS). Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31805
Vancouver
Kenborg L, Asdahl PH, Bhatia S, Christensen J, Gudmundsdottir T, Hjorth L, et al. Treatment‐Related Risk Factors for Diabetes Mellitus in Childhood Cancer Survivors—A Case‐Cohort Study Within Adult Life After Childhood Cancer in Scandinavia (ALiCCS). Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31805
BibTeX
@article{Kenborg2025,
author = {Kenborg, Line and Asdahl, Peter H and Bhatia, Smita and Christensen, Jane and Gudmundsdottir, Thorgerdur and Hjorth, Lars and Howell, Rebecca and Krøyer, Anja and Jørgensen, Morten and Laursen, Michael R T and Lassen-Ramshad, Yasmin and de Fine Licht, Sofie and Nielsen, Thomas Tjørnelund and Rechnitzer, Catherine and Smith, Susan A and Wiebe, Thomas and Hasle, Henrik and Holmqvist, Anna S and ALiCCS study group, ALiCCS study group},
title = {Treatment‐Related Risk Factors for Diabetes Mellitus in Childhood Cancer Survivors—A Case‐Cohort Study Within Adult Life After Childhood Cancer in Scandinavia (ALiCCS)},
journal = {Pediatric Blood & Cancer},
year = {2025},
doi = {10.1002/pbc.31805}
}
EUVIMED